US Patent Issued to VANDA PHARMACEUTICALS on May 12 for "Methods of treating PDE IV-mediated diseases or conditions" (Maryland Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,915, issued on May 12, was assigned to VANDA PHARMACEUTICALS INC. (Washington).

"Methods of treating PDE IV-mediated diseases or conditions" was invented by Vuk Koprivica (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides methods and compositions for the treatment of PDE IV-mediated diseases or conditions, including inflammatory diseases or conditions, using a compound of Formula (I) or a pharmaceutically acceptable salt thereof:"

The patent was filed on Sept. 10, 2021, under Application No. 18/044,805.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-...